Self-Administered Nasal Influenza Vaccine: Immunogenicity and Feasibility of Group Administration

Trial Profile

Self-Administered Nasal Influenza Vaccine: Immunogenicity and Feasibility of Group Administration

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Apr 2014

At a glance

  • Drugs Influenza virus vaccine live (Primary)
  • Indications Influenza virus infections
  • Focus Pharmacodynamics
  • Acronyms SNIF
  • Most Recent Events

    • 03 Feb 2014 According to ClinicalTrials.gov record trial status changed to completed.
    • 10 Sep 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top